Bruce F Bell

Array ( [id] => 318855 [patent_doc_number] => 07521565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one or its salt' [patent_app_type] => utility [patent_app_number] => 10/574795 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3381 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521565.pdf [firstpage_image] =>[orig_patent_app_number] => 10574795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098497 [patent_doc_number] => 20050130956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof' [patent_app_type] => utility [patent_app_number] => 10/964559 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10819 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130956.pdf [firstpage_image] =>[orig_patent_app_number] => 10964559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567918 [patent_doc_number] => 07465807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Process for preparing benzimidazole thiophenes' [patent_app_type] => utility [patent_app_number] => 10/575210 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19259 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465807.pdf [firstpage_image] =>[orig_patent_app_number] => 10575210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098505 [patent_doc_number] => 20050130964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/963979 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13027 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130964.pdf [firstpage_image] =>[orig_patent_app_number] => 10963979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098597 [patent_doc_number] => 20050131056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/965659 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8444 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131056.pdf [firstpage_image] =>[orig_patent_app_number] => 10965659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107794 [patent_doc_number] => 20070066672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Benzimidazole derivatives and use thereof as peptide deformylase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/572415 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15273 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066672.pdf [firstpage_image] =>[orig_patent_app_number] => 10572415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011484 [patent_doc_number] => 20050065200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Prostaglandin EP4 antagonist' [patent_app_type] => utility [patent_app_number] => 10/952418 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6603 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065200.pdf [firstpage_image] =>[orig_patent_app_number] => 10952418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543531 [patent_doc_number] => 07169800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Imidazole compositions useful as inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 10/949027 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13018 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169800.pdf [firstpage_image] =>[orig_patent_app_number] => 10949027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884681 [patent_doc_number] => 07351726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Substituted oxadiazolidinediones' [patent_app_type] => utility [patent_app_number] => 10/947856 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12639 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351726.pdf [firstpage_image] =>[orig_patent_app_number] => 10947856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255298 [patent_doc_number] => 20050075338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation' [patent_app_type] => utility [patent_app_number] => 10/949119 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45431 [patent_no_of_claims] => 140 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075338.pdf [firstpage_image] =>[orig_patent_app_number] => 10949119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000409 [patent_doc_number] => 20070043043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Benzimidazole derivates: preparation and pharmaceutical applications' [patent_app_type] => utility [patent_app_number] => 10/572958 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31386 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043043.pdf [firstpage_image] =>[orig_patent_app_number] => 10572958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494761 [patent_doc_number] => 07211671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)' [patent_app_type] => utility [patent_app_number] => 10/946418 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25150 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211671.pdf [firstpage_image] =>[orig_patent_app_number] => 10946418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972555 [patent_doc_number] => 20050038265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines' [patent_app_type] => utility [patent_app_number] => 10/943327 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9501 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038265.pdf [firstpage_image] =>[orig_patent_app_number] => 10943327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034553 [patent_doc_number] => 20050033063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines' [patent_app_type] => utility [patent_app_number] => 10/943315 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9485 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033063.pdf [firstpage_image] =>[orig_patent_app_number] => 10943315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 783070 [patent_doc_number] => 06992195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with arylamines' [patent_app_type] => utility [patent_app_number] => 10/943277 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6065 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992195.pdf [firstpage_image] =>[orig_patent_app_number] => 10943277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774312 [patent_doc_number] => 07002024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Production of a N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines' [patent_app_type] => utility [patent_app_number] => 10/943324 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6061 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/002/07002024.pdf [firstpage_image] =>[orig_patent_app_number] => 10943324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034552 [patent_doc_number] => 20050033062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines' [patent_app_type] => utility [patent_app_number] => 10/943313 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9499 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033062.pdf [firstpage_image] =>[orig_patent_app_number] => 10943313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793293 [patent_doc_number] => 06982339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines' [patent_app_type] => utility [patent_app_number] => 10/943282 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6064 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982339.pdf [firstpage_image] =>[orig_patent_app_number] => 10943282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011473 [patent_doc_number] => 20050065189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Thiazole derivatives as cannabinoid receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/942021 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5699 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065189.pdf [firstpage_image] =>[orig_patent_app_number] => 10942021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779407 [patent_doc_number] => 06995275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => 'Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds' [patent_app_type] => utility [patent_app_number] => 10/935940 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6685 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995275.pdf [firstpage_image] =>[orig_patent_app_number] => 10935940 [rel_patent_id] =>[rel_patent_doc_number] =>)